양격산화탕은 9가지의 약재로 구성된 처방으로 한의학적 뇌졸중 치료에 가장 널리 사용되는 처방 중 하나이며, 주로 사상체질이론의 소양인 뇌졸중 치료에 적용된다. 본 연구는 실험동물을 ...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A106452846
2019
English
KCI등재
학술저널
1258-1266(9쪽)
0
0
상세조회0
다운로드국문 초록 (Abstract)
양격산화탕은 9가지의 약재로 구성된 처방으로 한의학적 뇌졸중 치료에 가장 널리 사용되는 처방 중 하나이며, 주로 사상체질이론의 소양인 뇌졸중 치료에 적용된다. 본 연구는 실험동물을 ...
양격산화탕은 9가지의 약재로 구성된 처방으로 한의학적 뇌졸중 치료에 가장 널리 사용되는 처방 중 하나이며, 주로 사상체질이론의 소양인 뇌졸중 치료에 적용된다. 본 연구는 실험동물을 이용한 뇌졸중에 대한 양격산화탕의 효과에 대한 연구가 전무하여, photothrombosis로 유발된 허혈성 마우스모델을 이용하여 양격산화탕의 효과를 살펴 보았다. 동물행동학적 변화와 더불어 뇌손상에 미치는 영향을 뇌경색 용적에 대한 조직학적 검색 및 신경염증과 신생세포에 대한 면역조직화학적 검색으로 살펴 보았다. 동물행동학적 결과로 보아, 양격산화탕은 뇌허혈에 의해 손상된 운동기능, 즉 wire grip과 rotarod test에 의한 운동조정과 균형 능력 등에 대한 기능적 회복을 보였으며, 이는 조직학적 검색으로 관찰된 뇌경색 용적의 축소를 동반하였다. 면역조직화학적 결과를 보면, 양격산화탕은 tumor necrosis factor-α와 myeloperoxidase 면역반응세포의 수를 현저히 감소시켰다. 이와 반대로 양격산화탕은 glial fibrillary acidic protein와 ionized calcium-binding adapter molecule 1 면역반응세포의 수를 현저히 증가시켰다. 또한 양격산화탕은 Ki67/doublecortin 면역반응세포의 수를 현저히 증가시켰다. 이상의 결과로 보아, 양격산화탕은 항염증, astrocyte와 microglia의 활성화 및 신경세포의 증식을 통해 뇌경색 용적을 감소시키며, 이는 뇌허혈성 운동장애에 대한 완화 효과로 이어 지는 것을 알 수 있다. 따라서 양격산화탕은 뇌손상에 대한 신경기능적 완화효과를 보여 줌으로서 뇌졸중 환자에 대한 유효한 치료제로 사료된다.
다국어 초록 (Multilingual Abstract)
Yangkyuksanhwa-Tang (YKSH), consisting of nine different herbs, is commonly used in Soyangin-type individuals with stroke, based on the Sasang Constitution Theory in Korea. However, no evidence has yet confirmed a beneficial effect of YKSH in ischemic...
Yangkyuksanhwa-Tang (YKSH), consisting of nine different herbs, is commonly used in Soyangin-type individuals with stroke, based on the Sasang Constitution Theory in Korea. However, no evidence has yet confirmed a beneficial effect of YKSH in ischemic stroke treatment. In this study, we investigated the effects of YKSH on ischemic brain injury in a mouse model of cerebral ischemia. Focal cerebral ischemia in mice was induced by photothrombosis, and behavioral recovery was evaluated. Infarct volume, inflammation, and newly generated cells were evaluated by histology and immunochemistry. YKSH treatment resulted in a significant recovery from the motor impairments induced by focal cerebral ischemia, as determined with wire grip and rotarod tests. YKSH treatment also decreased the infarct volume and the number of cells positive for tumor necrosis factor-α and myeloperoxidase when compared with a vehicle-treated control group. By contrast, YKSH treatment considerably increased the number of cells positive for glial fibrillary acidic protein and ionized calcium-binding adapter molecule 1, as well as the number of cells doubly positive for Ki67/doublecortin when compared with the vehicle-treated group. These results suggest that YKSH treatment attenuated the infarct size by anti-inflammatory action, astrocyte and microglia activation, and neuronal proliferation, thereby facilitating neurofunctional recovery from a cerebral ischemic assault. YKSH could therefore be a potential treatment for neurofunctional restoration of the injured brains of patients with stroke.
목차 (Table of Contents)
참고문헌 (Reference)
1 Jeong, H. J., "Yangkyuk-Sanhwa-Tang induces changes in serum cytokines and improves outcome in focal stroke patients" 39 : 63-68, 2002
2 Breckwoldt, M. O., "Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase" 105 : 18584-18589, 2008
3 Liu, S., "Tissue plasminogen activator-based nanothrombolysis for ischemic stroke" 15 : 173-184, 2018
4 Widmann, C., "The traditional Chinese medicine MLC 901 inhibits inflammation processes after focal cerebral ischemia" 8 : 18062-, 2018
5 Burns, J. J., "The influence of traditional herbal formulas on cytokine activity" 278 : 140-159, 2010
6 Iadecola, C., "The immunology of stroke : from mechanisms to translation" 17 : 796-808, 2011
7 Jeffers, M. S., "Synergistic effects of enriched environment and task-specific reach training on poststroke recovery of motor function" 49 : 1496-1503, 2018
8 Langhorne, P., "Stroke rehabilitation" 377 : 1693-1702, 2011
9 Li, S, "Spasticity, Motor Recovery, and Neural Plasticity after Stroke" 8 : 120-, 2017
10 Choudhury, G. R., "Reactive astrocytes and therapeutic potential in focal ischemic stroke" 85 : 234-244, 2016
1 Jeong, H. J., "Yangkyuk-Sanhwa-Tang induces changes in serum cytokines and improves outcome in focal stroke patients" 39 : 63-68, 2002
2 Breckwoldt, M. O., "Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase" 105 : 18584-18589, 2008
3 Liu, S., "Tissue plasminogen activator-based nanothrombolysis for ischemic stroke" 15 : 173-184, 2018
4 Widmann, C., "The traditional Chinese medicine MLC 901 inhibits inflammation processes after focal cerebral ischemia" 8 : 18062-, 2018
5 Burns, J. J., "The influence of traditional herbal formulas on cytokine activity" 278 : 140-159, 2010
6 Iadecola, C., "The immunology of stroke : from mechanisms to translation" 17 : 796-808, 2011
7 Jeffers, M. S., "Synergistic effects of enriched environment and task-specific reach training on poststroke recovery of motor function" 49 : 1496-1503, 2018
8 Langhorne, P., "Stroke rehabilitation" 377 : 1693-1702, 2011
9 Li, S, "Spasticity, Motor Recovery, and Neural Plasticity after Stroke" 8 : 120-, 2017
10 Choudhury, G. R., "Reactive astrocytes and therapeutic potential in focal ischemic stroke" 85 : 234-244, 2016
11 Parent, J. M., "Rat forebrain neurogenesis and striatal neuron replacement after focal stroke" 52 : 802-813, 2002
12 Lapchak, P. A., "Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone(PBN)and 2, 2, 6, 6-tetramethylpiperidine-N-oxyl(TEMPO)in a rabbit thromboembolic stroke model : combination studies with the thrombolytic tissue plasminogen activator" 32 : 147-153, 2001
13 Lindekleiv, H., "Percutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic stroke" 10 : 2018
14 Zhang, Z. G., "Neurorestorative therapies for stroke : underlying mechanisms and translation to the clinic" 8 : 491-500, 2009
15 Zhang, X., "Neuroprotective effects of matrix metalloproteinases in cerebral ischemic rats by promoting activation and migration of astrocytes and microglia" 146 : 136-142, 2019
16 Minnerup, J., "Neuroprotection for stroke : current status and future perspectives" 13 : 11753-11772, 2012
17 Sandvig, I., "Neuroplasticity in stroke recovery, The role of microglia in engaging and modifying synapses and networks" 47 : 1414-1428, 2018
18 de Lima, N. M., "Neuroinflammatory response to experimental stroke is inhibited by boldine" 28 : 223-237, 2017
19 Zimmermann, G. R., "Multitarget therapeutics : when the whole is greater than the sum of the parts" 12 : 34-42, 2007
20 Chen, Z., "Microglia and neuroprotection" 136 (136): 10-17, 2016
21 Liu, L., "Korean Red Ginseng pretreatment protects against long-term sensorimotor deficits after ischemic stroke likely through Nrf2" 12 : 74-, 2018
22 Minagar, A., "Interferon(IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier" 10 : 299-307, 2003
23 Jeong, H. J., "Inhibitory effect of Yangkyuk-Sanhwa-Tang on inflammatory cytokine production in peripheral blood mononuclear cells from the cerebral infarction patients" 117 : 525-537, 2007
24 Liguz-Lecznar, M., "Inhibition of Tnf-alpha R1 signaling can rescue functional cortical plasticity impaired in early post-stroke period" 36 : 2877-2884, 2015
25 Gu, Y., "Herbal medicines for ischemic stroke : combating inflammation as therapeutic targets" 9 : 313-339, 2014
26 Shin, M. G., "Effects of Yanggyuksanhwa-Tang on cerebral blood flow and ischemic brain damage in rats" 13 : 165-176, 2001
27 Lee, J. M., "Dongeui Soosebowon" Yeogang 2003
28 Huang, J., "CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice" 44 : 190-197, 2013
29 Anderson, M. A., "Astrocyte scar formation aids central nervous system axon regeneration" 532 : 195-200, 2016
30 Peng, T., "Anti-inflammatory effects of traditional Chinese medicines on preclinical in vivo models of brain ischemia-reperfusion-injury : prospects for neuroprotective drug discovery and therapy" 10 : 204-, 2019
31 Fernandes, M. Y. D., "(-)-alpha-bisabolol prevents neuronal damage and memory deficits through reduction of proinflammatory markers induced by permanent focal cerebral ischemia in mice" 842 : 270-280, 2019
해양세균 Agarivorans sp. BK-1의 분리 및 β-아가라제의 특성 규명
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2027 | 평가예정 | 재인증평가 신청대상 (재인증) | |
2021-01-01 | 평가 | 등재학술지 유지 (재인증) | |
2018-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2015-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2011-08-03 | 학술지명변경 | 외국어명 : Korean Journal of Life Science -> Journal of Life Science | |
2011-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2009-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2007-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2004-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | |
2003-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | |
2001-07-01 | 평가 | 등재후보학술지 선정 (신규평가) |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.37 | 0.37 | 0.42 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.43 | 0.43 | 0.774 | 0.09 |